COMMUNICATION
News & Press Release
Neurobiogen, applied for FDA ODD(Orphan Drug Designation) for 'Acute Spinal Cord Injury' treatment,
  • DATE : 2020-09-02
  • VIEWS : 2711
FILES
LIST